Advertisement

Topics

CryoLife Reports Preliminary Financial Results for Third Quarter 2018 in Anticipation of ...

17:00 EDT 15 Oct 2018 | BioMedReports - Blog

ATLANTA, Oct. 15, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, in anticipation of discussions

Read more...

Original Article: CryoLife Reports Preliminary Financial Results for Third Quarter 2018 in Anticipation of ...

NEXT ARTICLE

More From BioPortfolio on "CryoLife Reports Preliminary Financial Results for Third Quarter 2018 in Anticipation of ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...